Thank You For Your Interest in IntegriCell™

Poster Presentation

Cryo-processed Leukapheresis Using Automated Closed System: A High-Quality Starting Material for Autologous and Allogeneic CAR-T Cell Therapy Manufacturing

We appreciate your interest in learning how Cryoport Systems’ IntegriCell services are advancing the cryopreservation of leukapheresis starting material. This poster presentation demonstrates how automation, standardization, and data-driven workflows can help you reduce variability and build confidence in your cell therapy programs. From standardized cryopreservation to integrated supply chain solutions, Cryoport Systems is Enabling the Outcome™ to future-proof your advanced therapy programs.